Support Alert

Drug Safety update: Antiepileptic drugs: updated advice on switching between different manufacturers’ products

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug safety update for Antiepileptic drugs. In addition to the 3 risk-based categories of antiepileptic drugs, patient-related factors should be considered when deciding whether it is necessary to maintain continuity of supply for a specific product.

Further details of the safety update, advice and recommendations are available on the MHRA website.